Introduction
Long chain polyunsaturated fatty acids (PUFAs) are enriched in developing brain and are essential for normal development of the central nervous system (reviewed in Neuringer et al. 1988; Wainwright 2002) . PUFAs play important roles in the development of visual, cognitive, attentional, and learning functions (Neuringer et al. 1988; Carlson and Neuringer 1999; Wainwright 2002; McCann and Ames 2005; Carlson 2009 ). PUFA deficiency in the brain is implicated in various neuropsychiatric/ neurodegenerative disorders, such as schizophrenia, depression, attention deficit hyperactivity disorder, Parkinson's disease and Alzheimer's disease (Freeman 2000; Richardson and Puri 2000; Salvati et al. 2006 ).
There are two major types of PUFAs: omega-3 (ω-3 or n-3) and omega-6 (ω-6 or n-6). Docosahexaenoic acid (DHA) and arachidonic acid (AA) represent the most abundant ω-3 and ω-6 PUFAs in brain, respectively. Important roles for PUFAs during brain development include: (i) integration into the phospholipids of cell membranes resulting from continuous membrane remodelling, which in turn modulates signal transduction, neurotransmission, cell motility, and the composition and formation of lipid rafts (Stillwell et al. 2005; Grossfield et al. 2006) ; (ii) regulation of the expression of genes implicated in genesis, proliferation, differentiation and migration of neural cells through binding and activation of nuclear receptors such as peroxisome proliferator activating receptors (PPARs) and/or retinoid X receptors (RXRs) (Kitajka et al. 2004; Schroeder et al. 2008) ; and (iii) serving as precursors for eicosanoids which are key messengers involved in inter-and intracellular signaling cascades in brain (Purasiri et al. 1997; Jump 2002; Venkatraman and Meksawan 2002) .
As PUFAs are hydrophobic molecules, their trafficking in the aqueous cytoplasm is facilitated by intracellular protein vehicles, called fatty acid-binding proteins (FABPs) . FABPs belong to the intracellular lipid binding protein (iLBP) family which binds fatty acids, retinoids and other hydrophobic compounds and mediates their physiological functions (reviewed in Storch and Corsico 2008) . FABPs exhibit tissue-specific expression patterns and distinct ligand preferences, although they all share a conserved 3-dimensional structure consisting of two orthogonal β-sheets and an α-helical cap (Hanhoff et al. 2002; Haunerland and Spener 2004) . Ten FABPs have been identified in mammals to date, with three phylogenetically-related FABPs, FABP3, FABP5 and FABP7, described in the developing and/or adult brain ( Fig. 1) (Schoentgen et al. 1989; Godbout 1993; Bennett et al. 1994; Feng et al. 1994; Kurtz et al. 1994; Owada et al. 1996; Liu et al. 1997; DenovanWright et al. 2000; Liu et al. 2004; Liu et al. 2007) . Each of these three FABPs shows distinct preference for specific fatty acids. The main purpose of this review is to summarize current knowledge regarding the cellular/subcellular distribution, transcriptional regulation and function of these three FABPs in the normal and diseased brain of humans, as well as in the developing brain of model organisms.
Developmental expression patterns of FABPs in the brain
The spatio-temporal expression patterns of FABP3, FABP5 and FABP7 in the developing rodent brain have been thoroughly investigated, with similar results obtained in mouse and rat (Kuhar et al. 1993; Feng et al. 1994; Kurtz et al. 1994; Owada et al. 1996) . FABP7 levels increase as a function of embryonic mouse brain development, reaching a peak at embryonic day (ED)14, and undergoing significant decreases from post-natal day (P)1 to P14 (Kuhar et al. 1993; Feng et al. 1994; Owada et al. 1996) . Fabp7 mRNA is present at low levels and in restricted regions of the adult olfactory bulb, hippocampus and cerebellum (Kuhar et al. 1993; Feng et al. 1994; Owada et al. 1996; Owada and Kondo 2003) . In contrast, Fabp3 mRNA is barely detectable in brain during embryonic development and the levels gradually increase after birth until adulthood (Owada et al. 1996) . Fabp5 mRNA is detected in mid-term embryonic rat brain, reaches its peak at birth, and gradually decreases from P1 to P21 (Owada et al. 1996) . Like Fabp7, Fabp5 is only weakly expressed in adult rat brain (Owada et al. 1996) . The temporal pattern of Fabp7 RNA expression parallels neurogenesis, whereas that of Fabp3 correlates with synaptogenesis and myelinogenesis ( Fig. 2A) . The spatial distribution of FABPs in the developing rodent brain has been previously described by Owada et al. (1996) and is summarized in Table 1 . Several conclusions can be drawn from the spatial and temporal expression patterns of FABP3, FABP5 and FABP7. First, dynamic changes in expression are observed for all three Fabp genes during brain development, with the patterns of expression correlating with specific developmental processes such as establishment of the radial glial fiber system (Fabp7), neuronal cell differentiation and migration (Fabp7, Fabp5), and neurite formation and synapse maturation (Fabp3) (Sellner et al. 1995; Pu et al. 1999; Liu et al. 2000; Owada and Kondo 2003; Owada et al. 2006) . Second, localization of different Fabps in the developing brain is either redundant or complementary. For instance, at P7, (Owada et al. 1996) . Dynamic changes in the levels of DHA (22:6n-3), AA (22:4n-6) and PA (18:0) in the developing rat brain and human brain are based on Green and Yavin (1996) and Martinez et al. (1992) , respectively.
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both Fabp7 and Fabp5 mRNA are present in the Bergmann glia of the cerebellum, while Fabp3 and Fabp5 mRNA co-localize in the neurons of the olfactory bulb. However, for the most part Fabps show complementary distribution patterns, with transcripts of different Fabps expressed in specific brain regions, cell layers, cell types and developmental stages (Owada and Kondo 2003; Owada et al. 2006) . Third, transcripts and proteins of all three Fabps localize to both the cytoplasm and nucleus of either glia or neurons Owada and Kondo 2003) . The relative intensity of Fabp mRNA and protein in cytoplasm and nucleus changes during development . The presence of FABPs in the nucleus suggests a role in the modulation of gene expression, presumably by controlling the availability of the fatty developing zebrafish brain (Fig. 3) . Of all fabps expressed in zebrafish brain, fabp7a transcripts were the most abundant and showed the widest distribution in the developing forebrain, midbrain, hindbrain, spinal cord as well as the retina. Similar to mammalian FABP7, zebrafish fabp7a is also the earliest gene expressed during brain development, although fabp7a mRNA is not spatially restricted when it is first detected at the early segmentation stage (Liu et al. 2004) . The levels of zebrafish fabp3 transcripts decrease as the brain develops, with barely detectable levels observed 48 hours post-fertilization (hpf). In contrast, fabp7a and fabp11a transcripts are still abundant at this stage. Thus, the relative temporal expression patterns of the fish fabp3 and fabp7 in the developing brain are different from their mamma- Fig. 3 . Comparative expression patterns of FABPs in the developing brain of zebrafish (Danio rerio). fabp7a, fabp11a and fabp3 transcripts in zebrafish embryos at 11, 24, 36 and 48 hours post-fertilization (hpf) were detected by whole mount in situ hybridization using specific DIG-dUTP-labeled antisense RNA probes. Images are dorsal views of the zebrafish embryos except for III-3, which is a lateral view. The head is on the left. Abbreviations: Fb, forebrain; Te, tectum; Re, retina; Hb, hindbrain; R4, rhombomere 4; Dc, diencephalon; Le, lens; Sc, spinal cord; So, somites; Li, liver; Cg, Cranial ganglion. Arrowheads indicate brain vasculature. The data shown in this figure were compiled from our previous publications (Liu et al. 2004; Liu et al. 2007 ) with permission from the editor.
acid ligands required for nuclear receptor PPAR and/ or RXR activity (Kitajka et al. 2004; Schroeder et al. 2008) .
The first avian FABP7 (also known as R-FABP) was identified by Godbout (1993) by screening a cDNA library prepared from embryonic chick retina at ED3.5. Northern blot analysis revealed elevated levels of FABP7 mRNA in the ED3.5 retina, with a 50 to 100-fold decrease in transcript levels observed from ED3.5 to ED19. In contrast, FABP7 mRNA levels increased 30 to 40-fold in the differentiating brain from ED3.5 to ED19 (Godbout 1993) . Godbout et al. (1995) later analyzed the cellular and subcellular distribution of FABP7 mRNA and protein in the developing chick retina. At early stages of development, from ED3 to ED7, FABP7 was found throughout the retina, with accumulation in the neurites of ganglion cells. By ED11, FABP7 was mainly found in the inner nuclear layer, inner plexiform layer, optic nerve fiber layer and non-pigmented ciliary epithelium (Godbout et al. 1995) . In contrast to mammalian brain FABP7 which is primarily found in radial glial cells (Kurtz et al. 1994; Feng and Heintz 1995) , chicken FABP7 localizes to retinal neurons (Sellner 1993) . The spatio-temporal expression pattern of FABP7 and other FABPs in the developing avian brain has yet to be described.
In zebrafish, five fabp genes have been identified in developing and/or adult brain. These include duplicate fabp7 genes (fabp7a and fabp7b), duplicate fabp11 genes (fabp11a and fabp11b) and a single fabp3 gene (Liu et al. 2003a; Liu et al. 2003b; Liu et al. 2004; Liu et al. 2007; Karanth et al. 2008) . As fabp7b and fabp11b transcripts are expressed at negligible levels in the developing brain, we compared the spatiotemporal pattern of fabp7a, fabp11a and fabp3 in the lian counterparts (Owada and Kondo 2003; Liu et al. 2004) . The zebrafish fabp11a (also named fabp4) shows restricted expression in the developing diencephalon, lens and brain vasculature (Agulleiro et al. 2007; Liu et al. 2007 ). As fabp11a is the only FABP gene other than fabp7 and fabp3 that is expressed in the developing brain, this suggests a possible orthologous relationship with the mammalian Fabp5. Of note, both the zebrafish fabp11a and the mammalian Fabp5 are also expressed in lens (Wen et al. 1995; Liu et al. 2007 ).
Fatty acid ligand preference for FABPs in developing brain
Commonly used approaches for measuring binding of FABPs to their fatty acid ligands include: Isothermal Titration Calorimetry (ITC), ANS Fluorometry and Lipidex 1000. Despite methoddependent and species-dependent variation in absolute dissociation constant (K d ) values, FABP3, FABP5 and FABP7 each demonstrate preferences for specific classes of fatty acids (Table  2 ). For example, ITC analysis of human FABP3 in the presence of ω-3 PUFA (DHA, EPA), ω-6 PUFA (LOA) and monounsaturated fatty acid (MUFA) [oleic acid (OA)] yields K d values in the range of 3-4 μM, 1 μM and 0.8 μM, respectively (Balendiran et al. 2000) . In support of a preference for ω-6 PUFA, Fabp3 gene-ablated mice show impairment of AA incorporation into the brain (Murphy et al. 2005) . These in vivo data suggest a requirement for FABP3 binding to ω-6 PUFA that is not compensated by expression of other FABPs in the brain (FABP5 and FABP7).
Rat and human FABP5 both show a preference for the more saturated fatty acids, generating K d values of 0.168 μM (ANS Fluorometry) and 0.290 μM (Lipidex) for stearic acid (SA) compared to K d values ≥0.4 μM for ω-3 and ω-6 PUFAs (Liu et al. 2008; Hohoff et al. 1999) . In comparison to FABP3 and FABP5, human FABP7 has the highest affinity for ω-3 PUFA, with a K d of 0.053 μM when bound to DHA. This is in contrast to K d values of 0.207 μM for FABP7-AA and 7.1 μM for FABP7-stearic acid (SA) (Balendiran et al. 2000) . Although not numerically consistent with the K d of 0.010 μM reported for murine FABP7-DHA using Lipidex (Xu et al. 1996) , both ITC and Lipidex demonstrate that FABP7 preferentially binds to ω-3 PUFA. Green et al. (1996) and Martinez et al. (1992) have examined the fatty acid composition of the developing rat and human brain, respectively. In rat, the levels of saturated fatty acids (16:0; 18:0) and AA (ω-6 PUFA) remain stable throughout neural development. In contrast, the levels of DHA in rat brain are relatively low during neurogenesis (~50% of AA levels and 25% of PA and SA levels) and increase during synaptogenesis (to ~50% of PA and SA levels and close to 100% of AA levels by P8) ( Fig. 2A) . A similar trend is observed in the developing human brain, with stable levels of saturated fatty acids from 30 weeks gestation to birth. A slight decrease in AA levels is observed during this period of time, whereas synaptogenesis and myelinogenesis is accompanied by an ~20% increase in DHA levels (Fig. 2B) . As there is no data on the fatty acid composition of the human brain during neurogenesis, one can only postulate that, similar to what has been observed in rat brain, the transition from neurogenesis to synaptogenesis is accompanied by a significant increase in DHA in the developing human brain. Although there is some overlap in the temporal expression pattern and fatty acid binding affinities of FABP3, FABP5 and FABP7, it is clear from in vitro binding studies that these FABPs have specific fatty acid ligand preferences (i.e. ω-6 PUFA for FABP3, saturated fatty acids for FABP5 and ω-3 PUFA for FABP7). The temporal expression patterns of FABP3, FABP5 and FABP7 during brain development, combined with the temporal availability of saturated fatty acids, ω-6 PUFA and ω-3 PUFA, suggest that different FABPs and their fatty acid ligands play specialized roles during neurogenesis and synaptogenesis.
FABP

Emerging functions for FABPs in brain development
FABP7 and neuronal cell migration
During brain development, neuronal precursor cells proliferate in the ventricular zone of the developing neocortex. Neurons then travel from their origin or "birth place" using radial glial fibers that serve as a scaffold for migrating neuronal cells. Each subsequent wave of migrating cells travel past their predecessors, forming layers in an inside-out manner, i.e. the youngest neurons are the closest to the cortical surface (Rakic 1972; Nadarajah and Parnavelas 2002) . It has been estimated that as much as 90% of neuronal migration in the cortex is mediated by radial glial cells (Sidman and Rakic 1973; Hatten 1999) .
The mammalian FABP7 is specifically expressed in radial glial cells during brain development (Feng et al. 1994; Kurtz et al. 1994; Hartfuss et al. 2001 ). Feng et al. (1994 used an in vitro neuron-glia co-culture system to investigate whether FABP7 plays a role in the establishment of a glial fiber system and neuronal migration. When purified anti-FABP7 antibody was added to the neuron-glia culture, both glial cell processes extension and neuronal migration were blocked, while cell proliferation and adhesion were not affected (Feng et al. 1994) . Subsequent investigations further demonstrated that expression of FABP7 in radial glial cells is induced by the presence of migrating neurons (Feng and Heintz 1995) and that this induction is mediated by the Notch signalling pathway (Anthony et al. 2005) .
Pax6 and GGF/neuregulin also mediate migrating neuronradial glia interactions. Both these molecules control FABP7 expression in the radial glial cells of the developing rat brain (Anton et al. 1997; Arai et al. 2005) . These studies suggest that FABP7 is a critical molecule in radial glial cells, on one hand functioning as a sensor for neuronal signals, and on the other hand modulating radial glia differentiation and neuronal migration.
FABP7-expressing cells as neural progenitors
As mentioned above, FABP7 is present at very early developmental stages in both mammalian and fish brains. Mammalian FABP7 is specifically expressed in the neuroepithelial cells and radial glial cells of the ventricular and subventricular zones, the hot spots of neurogenesis (Feng et al. 1994; Kurtz et al. 1994; Owada et al. 2006) . In addition to their role in neuronal cell guidance, radial glial cells have been shown to act as neural stem/ progenitor cells during brain development (Malatesta et al. 2000; Miyata et al. 2001; Noctor et al. 2001; Malatesta et al. 2003; Anthony et al. 2004) . Anthony et al. (2004) used a 1.6 kb FABP7 promoter-driven Cre/Rosa26 Cre reporter double transgenic mice for fate mapping analysis. They found that all FABP7-expressing radial glial cells, regardless of location within the brain, go through a neuron generating stage. These authors concluded that FABP7-expressing radial glial cells give rise to most of the neurons in the brain. Furthermore, analysis of Fabp7-/-mice revealed dramatic decreases in the number of astrocytes, neural stem cells and early progenitor cells in the developing brain (Watanabe et al. 2007 ). Fabp7-/-mice also showed decreased numbers of late progenitor cells and attenuated neurogenesis in the developing hippocampus compared to wild-type mice (Watanabe et al. 2007 ). Knockdown of FABP7 in cultured rat neuroepithelial cells results in decreased proliferation, loss of processes and induction of premature neurogenesis, suggesting a role for FABP7 in the maintenance of proliferation (Arai et al. 2005) . FABP7 may therefore play a key role in neurogenesis, by maintaining the pool of neural stem/ progenitor cells (Watanabe et al. 2007 ).
Role of FABP3 and FABP5 in neuronal differentiation
During brain development, specific biochemical, physiological and morphological properties must be acquired by neuroprogenitor cells to allow differentiation along the neuronal cell lineage. The coordinated regulation of gene expression is fundamental to the control of neuronal cell differentiation. FAPB5 is specifically found in the differentiating neurons of the developing rat cerebral cortex and retina. FABP5 mRNA and protein levels are markedly higher in the prenatal and early postnatal neurons compared to adult neurons, suggesting a function for this FABP in neuronal differentiation (Liu et al. 1997; Liu et al. 2000) . Other evidence in support of a role for FABP5 in neuronal cell differentiation is the observation that FABP5 is induced in injured and regenerating neurons (De Leon et al. 1996; Owada et al. 1997) . FABP5 is also upregulated with NGF-induced neurite growth in rat pheochromocytoma cells (PC12), a model system for neuronal differentiation (Allen et al. 2000) . Depletion of FABP5 in PC12 using an antisense Fabp5 construct significantly reduces NGF-mediated neurite growth, suggesting a role for FABP5 in axonal development and regeneration (Allen et al. 2000) . Of note, no brain phenotype has been reported thus far in Fabp5 knockout mice, suggesting that other FABPs may compensate for loss of FABP5 function (Owada et al. 2002) .
FABP3 is expressed in mouse brain at relatively late developmental stages compared to Fabp7 and Fabp5, with barely detectable levels until ED17-19 (Sellner et al. 1995; Owada et al. 1996) . Based on its spatio-temporal expression pattern in mouse brain, Sellner et al. (1995) proposed that FABP3 is involved in neurite formation and synapse maturation. As Fabp3-null mouse brains show a reduction in both the incorporation of AA and the proportion of total ω-6 fatty acids in the major phospolipid classes, it was concluded that FABP3 may be involved in the uptake and metabolism of ω-6 fatty acids in the developing brain (Murphy et al. 2005) .
Role of FABPs in axis patterning of the developing brain
As the brain develops from the neural plate, different regions of the brain need to establish spatial identities to generate the precise cytoarchitecture of the mature brain. Patterning along both the anterior-posterior (AP) axis and dorsal-ventral (DV) axis starts after the generation of the neural tube, which involves precisely-timed expression of developmentally regulated genes (Lumsden and Krumlauf 1996) . Several organizing centers in the early developing vertebrate brain are involved in local patterning of axis formation, including the midbrain-hindbrain boundary (reviewed by Rhinn and Brand 2001; Wurst and Bally-Cuif 2001) , the forebrain organizer (Shimamura and Rubenstein 1997; Houart et al. 1998) and the hindbrain-spinal cord border (Maden 2002) . However, the signaling mechanisms from organizing centers involved in neuronal and glial cell differentiation are not well understood. Isolating genes with restricted patterns of expression in organizing centers combined with mutant screening using model organisms would be a powerful approach toward understanding the signaling pathways governing axis patterning in vertebrate brain.
As FABP7 is expressed in the early developing brain and has cell signaling properties (Feng et al. 1994) , it is logical to postulate that FABP7 may play a role in neural axis patterning. For instance, the vertebrate hindbrain consists of several subdivided segthe same mechanism is not known.
The Notch signaling pathway
Notch proteins are single-pass transmembrane receptors which include four family members, NOTCH1, NOTCH2, NOTCH3 and NOTCH4. Notch proteins play a role in a variety of developmental processes by controlling cell fate decisions (reviewed by Lewis 1998; Gaiano and Fishell 2002; Rodriguez-Rivera et al. 2009 ). Both neural stem cells and intermediate neural progenitors respond to Notch receptor activation, but through differential action of the downstream effector C-promoter binding factor 1 (CBF1) (Mizutani et al. 2007) . A single binding site for CBF1 (5'-GTTCCCAGGC-3', conserved nucleotides underlined) has been mapped within the proximal promoter region of mouse Fabp7 and is required for Fabp7 expression in radial glial cells (Anthony et al. 2005) . Furthermore, FABP7 protein levels are significantly down-
Radial glia ments, called rhombomeres, each of which has distinct cellular and molecular characteristics (reviewed by Lumsden and Krumlauf 1996) . Rhombomere 4 (r4) is the first one to form in the developing vertebrate hindbrain and acts as a signaling center in hindbrain patterning (Graham and Lumsden 1993; Graham and Lumsden 1996; Maves et al. 2002) . In zebrafish, fabp7a transcripts specifically localize to a restricted region of r4 during the middle and late segmentation phase, suggesting an important role for the fabp7a product in patterning of the hindbrain (Liu et al. 2004) . Recent data indicate that Pbx homeodomain proteins may play a role in the patterning of zebrafish retina and optic tectum, and that one of the major downstream effectors of these transcription factors is FABP7 (French et al. 2007) . Indeed, zebrafish fabp7a mRNA is abundantly expressed in the developing retina and tectum from early embryonic stages (Liu et al. 2004 ) and its levels are markedly reduced in the pbx2/4-null embryos compared with the wild-type (French et al. 2007 ).
Regulation of FABP expression in developing brain
Nuclear factor I (NF1)
The nuclear factor I (NFI) gene family, including NFIA, NFIB, NFIC and NFIX, plays important roles in development (reviewed by Gronostajski 2000). NFIs are expressed in both glial cells and neurons. Examination of the neural development abnormalities in Nfia-/-mice provide direct evidence for the importance of this transcription factor in regulating gene expression in the developing brain (das Neves et al. 1999; Shu et al. 2003; Wong et al. 2007 ). cDNA microarray analysis of genes expressed in the brains of Nfia-/-and Nfia+/+ mice identify Fabp7 as significantly up-regulated (2.59-fold) as a consequence of NFIA disruption (Wong et al. 2007) . Three NFI-binding sites in the proximal promoter region of human FABP7 have been mapped (Bisgrove et al. 2000; Brun et al. 2009 ). FABP7 expression is modulated by differential phosphorylation of NFI in human malignant glioma cells (Bisgrove et al. 2000) . Whether transcription of FABP7 in the developing brain is regulated by regulated in the developing forebrain of mice lacking Notch1 and Notch3, indicating an essential role for Notch signaling in modulating Fabp7 expression in developing mouse brain (Anthony et al. 2005) .
The Reelin-Dab1 pathway
Reelin is a large secreted glycoprotein which controls cell-cell interactions critical for cell positioning and neuronal migration during brain development (D'Arcangelo et al. 1995) . Disabled-1 (DAB1) serves as the intracellular adaptor for Reelin and has also been shown to be involved in neuronal cell positioning in the developing brain (Howell et al. 1997; Howell et al. 1999) . DAB1 is tyrosine phosphorylated when Reelin binds to the lipoprotein receptors Very Low Density Lipoprotein Receptor (VLDLR) and Apolipoprotein E Receptor 2 (APOER2) on the cell membrane (Huang et al. 2005) . In mutant mice deficient for Reelin, DAB1, or Reelin receptors (VLDLR and APOER2), radial glial morphology is altered and the radial glial scaffold is impaired in the developing brain (Forster et al. 2002; Hartfuss et al. 2003; Weiss et al. 2003) . Reelin signalling affects FABP7 expression in radial glial cells both in vitro and in vivo Keilani and Sugaya 2008) and DAB1 is required for Reelin-mediated FABP7 expression .
A recent study of the role of Reelin in FABP7 induction in human neural progenitor cells revealed cross-talk between the Reelin and Notch signaling pathways (Keilani and Sugaya 2008) . Reelin treatment of these cells increased the levels of both the NOTCH1 intracellular domain (NICD) and FABP7, and DAB1 coimmunoprecipitated with NICD, indicating physical interaction between these molecules (Keilani and Sugaya 2008) . Interaction between Reelin-Dab1, Notch and FABP7 (BLBP) has also been demonstrated using the radial glial cells of Reeler mice (Sibbe et al. 2009 ). The inter-relationship between these major signaling molecules may be of significance in elucidating the links between the neuronal-radial glial signaling networks which regulate glial cell development, neuronal generation and migration.
Reelin is primarily secreted by neurons termed Cajal-Retzius cells, which establish early neuronal circuitry in the developing brain (Aguilo et al. 1999) . Secreted Reelin promotes the differentiation of progenitor cells into radial glia and affects the orientation of radial glia fibers, which serve as guides for migrating neurons (Fig. 4) . Interaction between Reelin and Notch signaling pathways has also been demonstrated in the migrating and differentiating neurons of the developing cerebral cortex (HashimotoTorii et al. 2008) . Reelin may therefore serve as a general signaling messenger to integrate the events associated with radial glia fiber formation and neuronal cell migration (Fig. 4) . Thus, Reelin-Dab1/Notch/FABP7 may represent a major and essential signaling pathway mediating neuronal-glial interaction during the early development of the brain.
As FABP3 and FABP5 are expressed in the neurons of developing brain and their expression patterns correlate with neuronal cell differentiation and/or migration (Sellner et al. 1995; Liu et al. 2000) , it will be interesting to know whether the neuronal ReelinDab1/Notch signaling pathway also functions through a neuronal FABP (FABP3 or FABP5) downstream effector, as it does for FABP7 in radial glial cells (Anthony et al. 2005; Keilani and Sugaya 2008; Sibbe et al. 2009 ).
PAX6
The transcription factor PAX6 affects cell fate, cell proliferation and patterning during brain development in various species (Haubst et al. 2004) . In Pax6-deficient mice, the morphology, quantity and cell cycle distribution of radial glial cells in the developing cortex are altered (Gotz et al. 1998) . In the embryonic brains of rats, there is a strong correlation in the distribution patterns of PAX6 and FABP7. Pax6 mutation in rat embryonic brains results in dramatically reduced FABP7 whereas overexpression of PAX6 induces FABP7 expression, suggesting a role for PAX6 in the regulation of Fabp7 (Arai et al. 2005) . Although a putative cis-binding site for PAX6 was identified in the mouse Fabp7 promoter (Feng and Heintz 1995), it is not known whether PAX6 regulates Fabp7 transcription by directly interacting with this cis element or through other downstream effectors. It is noteworthy that FABP7 levels are not significantly affected by depletion of PAX6 in mouse brain (Gotz et al. 1998; Arai et al. 2005) , suggesting that PAX6-mediated regulation of FABP7 expression is species-dependent.
POU-domain proteins
POU-domain proteins are widely expressed in developing brain with distinct temporal and spatial patterns (He et al. 1989; Alvarez-Bolado et al. 1995) . Using an in vivo reporter transgenic mouse model, Josephson et al. (1998) tested the ability of serial deletions of the proximal 5' upstream region of Fabp7 (Feng and Heintz 1995) to drive developmentally-regulated Fabp7 expression in the embryonic CNS. A POU-domain protein PBX-1 and BRN-1 binding element was subsequently identified in the Fabp7 promoter (Josephson et al. 1998) . Mutant mice with germ-line deletion of the 9 bp POU-domain binding element lacked Fabp7 expression in the developing forebrain and midbrain, suggesting an essential role for POU-domain proteins in Fabp7 regulation (Josephson et al. 1998) .
In zebrafish, the levels of the fabp7a transcripts are dramatically reduced in the embryonic brain and retina when the POUdomain protein is knocked-down by morpholino transfection (French et al. 2007) , directly implicating this POU-domain protein in the regulation of fabp7 expression.
FABPs and brain disease
FABP7 is detected in human malignant glioma tumor biopsies and cell lines (Godbout et al. 1998) . cDNA array analysis of human glioblastoma tumor tissues has revealed a significant correlation between FABP7 and survival, suggesting that FABP7 could be an effective prognostic marker for glioblastoma patients with the worst survival rates (Liang et al. 2005; Kaloshi et al. 2007) . Furthermore, the nuclear distribution of FABP7 in epidermal growth factor receptor (EGFR)-positive glioblastoma tumors has been shown to be associated with a poor prognosis (Liang et al. 2006) . Expression of FABP7 in FABP-negative human malignant glioma cell lines enhances cell migration (Liang et al. 2005; Mita et al. 2007) , whereas FABP7 depletion by RNA interference suppresses migration (Mita et al. 2007) . Taken together, both clinical investigations and in vitro functional studies support an important role for FABP7 in the invasion and progression of human glioblastoma tumors. Further in vivo studies using animal models and exploration of the mechanism of action of FABP7 in the nucleus will shed light on its role in human glioblastoma.
Mental retardation is a typical phenotypic feature of Down syndrome (DS) patients. As FABPs are involved in development, establishment and maintenance of the central nervous system, it is reasonable to propose that FABPs may be implicated in DS pathogenesis. FABP7 has been found to be overexpressed in DS adult (Cheon et al. 2003) and fetal brains (Sanchez-Font et al. 2003) , whereas FABP3 is significantly decreased in DS adult brains (Cheon et al. 2003) . Furthermore, FABP7 upregulation in DS brains correlates with PKNOX1 gene-dosage imbalance. As PKNOX1 is a POU domain protein, it may directly control FABP7 expression by interacting with the Pbx/POU binding element in the FABP7 promoter (Sanchez-Font et al. 2003) .
Different lines of investigation directly associate FABP7 with schizophrenia, a psychiatric illness characterized by abnormalities in the perception or expression of reality (Watanabe et al. 2007) . Firstly, a quantitative trait locus (QTL) screening in a reference mice population demonstrates that Fabp7 is a promising candidate gene responsible for deficits in prepulse inhibition (PPI), a biological marker for schizophenia. Secondly, Fabp7-deficient mice show decreased PPI and impaired hippocampus neurogenesis. Thirdly, human FABP7 mRNA levels are significantly upregulated in the postmortum brains of schizophrenia patients compared with normal controls. Fourthly, there is a correlation between a single nucleotide polymorphism (SNP) variant within the second exon of human FABP7 and schizophrenia pathology (Watanabe et al. 2007) . As PPI impairment has been demonstrated in many other neuropsychiatric disorders (e.g. Alzheimer's disease, autism, bipolar disorders, Tourette syndrome, etc.) in addition to schizophrenia (Braff et al. 2001; Hejl et al. 2004) , the association between FABP7 and PPI status suggest that this gene is involved in the pathology of a wide range of neuropsychiatric and/or neurodegenerative diseases. Relationships between FABP3 and FABP5, and neurodegenerative diseases have also been reported (Gearhart et al. 2002; Steinacker et al. 2004 ).
Summary
FABP3, FABP5 and FABP7 are expressed in specific spatiotemporal patterns in the developing brain, with each showing preferential binding to different categories of long chain fatty acid ligands. Although the precise roles of these three FABPs in brain development awaits more in-depth studies, investigations using animal models have revealed a number of possible functions in neurogenesis, neuronal migration and differentiation, and axis patterning. Data to date indicate that FABP3, FABP5 and FABP7 are multi-functional proteins regulated by complex signaling networks and transcription factors. In particular, FABP7 in radial glial cells may be a major downstream effector of the Reelin-Dab1/ Notch signal pathway which plays a key role in the formation and maintenance of the radial glia scaffold and neuronal cell migration in the developing brain. FABP7 may serve as a mediator for the signaling crosstalk required between migrating neurons and radial glial cells. So far, FABP expression, its cellular distribution and genetic variation have been implicated in a number of brain diseases including human glioblastoma and neuropsychiatric disorders. Future investigations will shed additional light on the role of FABPs and their mechanisms of action in the development and health of the brain.
